Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Abstract Session

Osteoarthritis (OA) and related disorders
General Topic: Clinical Science

12S161: Abstracts: Osteoarthritis I: Clinical Trials (0817–0822)

Sunday, November 12, 2023
4:00 PM – 5:30 PM PT
Location: Room 6F/6C

On Demand In Person

Abstract oral session.

Non-CME

Presentations:

  • 4:00 PM – 4:10 PM PT
    WITHDRAWN
  • 4:10 PM – 4:15 PM PT
    Q&A
  • 4:15 PM – 4:25 PM PT
    Efficacy of XT-150, a Novel Non-Viral Gene Therapy Delivering IL-10v, on Moderate to Severe Pain Due to Osteoarthritis of the Knee: Results of a Phase 2 Trial

    Presenting Author: Howard Rutman, MD, MBA – Xalud Therapeutics

  • 4:25 PM – 4:30 PM PT
    Q&A
  • 4:30 PM – 4:40 PM PT
    Regression to the Mean for Physical Function and Quality of Life in Trials for Symptomatic Knee Osteoarthritis

    Presenting Author: Martin Englund, MD, PhD (he/him/his) – Lund University

  • 4:40 PM – 4:45 PM PT
    Q&A
  • 4:45 PM – 4:55 PM PT
    Radiographic and Pain Outcomes from a Phase 3 Extension Study Evaluating the Safety and Efficacy of Lorecivivint in Subjects with Severe Osteoarthritis of the Knee (OA-07): 36 Month Single Blind and Placebo Crossover Phase Results

    Presenting Author: Yusuf Yazici, MD – NYU Grossman School of Medicine

  • 4:55 PM – 5:00 PM PT
    Q&A
  • 5:00 PM – 5:10 PM PT
    Effects of Sprifermin on a Novel Outcome of Osteoarthritis Symptom Progression: Post Hoc Analysis of the FORWARD Study

    Presenting Author: Philip Conaghan, MD, PhD – University of Leeds

  • 5:10 PM – 5:15 PM PT
    Q&A
  • 5:15 PM – 5:25 PM PT
    From Biomarkers to Endotypes: Data-driven Identification of Knee Osteoarthritis Patients Subtypes

    Presenting Author: Monica Hannani, MSc (she/her/hers) – Nordic Bioscience

  • 5:25 PM – 5:30 PM PT
    Q&A